A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections
Sarah C. Vick(University of North Carolina at Chapel Hill), Jennifer M. Lund(Fred Hutch Cancer Center)
Cited by 11
Related Papers
Anti–PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells
|The Journal of Immunology|2021|25
Memory T cells possess an innate-like function in local protection from mucosal infection
|Journal of Clinical Investigation|2023|23